|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 38/26 | (2006.01) |
| A61K 38/28 | (2006.01) | ||
| A61P 3/10 | (2006.01) |
| (11) | Number of the document | 3010530 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14729687.5 |
| Date of filing the European patent application | 2014-06-13 | |
| (97) | Date of publication of the European application | 2016-04-27 |
| (45) | Date of publication and mention of the grant of the patent | 2018-12-26 |
| (46) | Date of publication of the claims translation | 2019-04-10 |
| (86) | Number | PCT/EP2014/062418 |
| Date | 2014-06-13 |
| (87) | Number | WO 2014/202483 |
| Date | 2014-12-24 |
| (30) | Number | Date | Country code |
| 13172341 | 2013-06-17 | EP | |
| 13192556 | 2013-11-12 | EP |
| (72) |
SOUHAMI, Elisabeth, FR
SILVESTRE, Louise, FR
|
| (73) |
Sanofi-Aventis Deutschland GmbH,
Brüningstra e 50, 65929 Frankfurt am Main,
DE
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | Kompozicija su fiksuotu insulino glargino / liksisenatido santikiu |
| INSULIN GLARGINE/LIXISENATIDE FIXED RATIO FORMULATION |
| Payment date | Validity (years) | Amount | |
| 2019-05-22 | 6 | 139.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2020-06-13 |